BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 11904335)

  • 21. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity.
    Legoix P; Bluteau O; Bayer J; Perret C; Balabaud C; Belghiti J; Franco D; Thomas G; Laurent-Puig P; Zucman-Rossi J
    Oncogene; 1999 Jul; 18(27):4044-6. PubMed ID: 10435629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of somatic APC mutations in rare extracolonic tumors of patients with familial adenomatous polyposis coli.
    Bläker H; Sutter C; Kadmon M; Otto HF; Von Knebel-Doeberitz M; Gebert J; Helmke BM
    Genes Chromosomes Cancer; 2004 Oct; 41(2):93-8. PubMed ID: 15287021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Wnt-signaling pathway proteins in intraductal papillary mucinous neoplasms of the pancreas: a tissue microarray analysis.
    Chetty R; Serra S; Salahshor S; Alsaad K; Shih W; Blaszyk H; Woodgett JR; Tsao MS
    Hum Pathol; 2006 Feb; 37(2):212-7. PubMed ID: 16426922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma.
    Schlosshauer PW; Pirog EC; Levine RL; Ellenson LH
    Mod Pathol; 2000 Oct; 13(10):1066-71. PubMed ID: 11048799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
    Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
    Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt/beta -catenin signaling is activated in human colon tumors.
    Yan D; Wiesmann M; Rohan M; Chan V; Jefferson AB; Guo L; Sakamoto D; Caothien RH; Fuller JH; Reinhard C; Garcia PD; Randazzo FM; Escobedo J; Fantl WJ; Williams LT
    Proc Natl Acad Sci U S A; 2001 Dec; 98(26):14973-8. PubMed ID: 11752446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Wnt-signaling pathway is not implicated in tumorigenesis of Merkel cell carcinoma.
    Liu S; Daa T; Kashima K; Kondoh Y; Yokoyama S
    J Cutan Pathol; 2007 Jan; 34(1):22-6. PubMed ID: 17214850
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutation of beta-catenin is an early event in chemically induced mouse hepatocellular carcinogenesis.
    Devereux TR; Anna CH; Foley JF; White CM; Sills RC; Barrett JC
    Oncogene; 1999 Aug; 18(33):4726-33. PubMed ID: 10467420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas.
    Ikeda S; Ishizaki Y; Shimizu Y; Fujimori M; Ojima Y; Okajima M; Sugino K; Asahara T
    Int J Oncol; 2002 Mar; 20(3):463-6. PubMed ID: 11836555
    [TBL] [Abstract][Full Text] [Related]  

  • 30. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin.
    Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Grieco M; Ramires P; Romito AM; De Rosa G; Piattelli A
    Anticancer Res; 2002; 22(2A):565-76. PubMed ID: 12014624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
    Pizzi S; Azzoni C; Tamburini E; Bottarelli L; Campanini N; D'Adda T; Fellegara G; Luong TV; Pasquali C; Rossi G; Delle Fave G; Camisa R; Bordi C; Rindi G
    Endocr Relat Cancer; 2008 Dec; 15(4):1013-24. PubMed ID: 18632876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of frizzled-related protein and Wnt-signalling molecules in invasive human breast tumours.
    Wong SC; Lo SF; Lee KC; Yam JW; Chan JK; Wendy Hsiao WL
    J Pathol; 2002 Feb; 196(2):145-53. PubMed ID: 11793365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical and molecular features of sporadic and FAP-associated duodenal adenomas of the ampullary and nonampullary mucosa.
    Wagner PL; Chen YT; Yantiss RK
    Am J Surg Pathol; 2008 Sep; 32(9):1388-95. PubMed ID: 18670349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
    Wu R; Zhai Y; Fearon ER; Cho KR
    Cancer Res; 2001 Nov; 61(22):8247-55. PubMed ID: 11719457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of beta-catenin signaling in the Wnt pathway.
    Kikuchi A
    Biochem Biophys Res Commun; 2000 Feb; 268(2):243-8. PubMed ID: 10679188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The significance of the Wnt pathway in the pathology of human cancers.
    Karim R; Tse G; Putti T; Scolyer R; Lee S
    Pathology; 2004 Apr; 36(2):120-8. PubMed ID: 15203747
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between protein expression and epigenetic and mutation changes of Wnt pathway-related genes in oral cancer.
    Yeh KT; Chang JG; Lin TH; Wang YF; Chang JY; Shih MC; Lin CC
    Int J Oncol; 2003 Oct; 23(4):1001-7. PubMed ID: 12963979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region.
    Buslei R; Nolde M; Hofmann B; Meissner S; Eyupoglu IY; Siebzehnrübl F; Hahnen E; Kreutzer J; Fahlbusch R
    Acta Neuropathol; 2005 Jun; 109(6):589-97. PubMed ID: 15891929
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunohistochemical and mutational analyses of Wnt signaling components and target genes in intrahepatic cholangiocarcinomas.
    Tokumoto N; Ikeda S; Ishizaki Y; Kurihara T; Ozaki S; Iseki M; Shimizu Y; Itamoto T; Arihiro K; Okajima M; Asahara T
    Int J Oncol; 2005 Oct; 27(4):973-80. PubMed ID: 16142313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.